Corton Capital’s Bristol-Myers Squibb BMY Stock Holding History

Corton Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,563	Closed	-$597K	–	201
2024 Q4	$597K	Sell	10,563 -1,499	-12%	-$83.8K	0.34%	6
2024 Q3	$624K	Buy	+12,062	New	+$566K	0.3%	24
2022 Q4	–	Sell	-3,528	Closed	-$251K	–	311
2022 Q3	$251K	Sell	3,528 -1,404	-28%	-$102K	0.31%	145
2022 Q2	$380K	Buy	+4,932	New	+$376K	0.36%	97

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corton Capital's BMY Position: Q1 2025 in Review

Corton Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 10,563 shares — an estimated $597K sold.

Corton Capital first reported a position in BMY in Q2 2022 and held it in 4 quarters. The position peaked at $624K in Q3 2024. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Corton Capital reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Corton Capital sold 10,563 Bristol-Myers Squibb shares in Q1 2025, an estimated $597K.
Corton Capital first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 4 quarters.
Corton Capital's Bristol-Myers Squibb position peaked at $624K in Q3 2024.
2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.